Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes

Authors:
  • JBJörg Benz
    Jörg Benz
  • ABAlfred Binggeli
    Alfred Binggeli
  • DBDenise Blum
    Denise Blum
  • MBMarkus Boehringer
    Markus Boehringer
  • UGUwe Grether
    Uwe Grether
  • HHHans Hilpert
    Hans Hilpert
  • BKBernd Kuhn
    Bernd Kuhn
  • HMHans Peter Märki
    Hans Peter Märki
  • MMMarkus Meyer
    Markus Meyer
  • KPKurt Püntener
    Kurt Püntener
  • SRSusanne Raab
    Susanne Raab

Abstract
No abstract available

This publication has 15 references indexed in Scilit: